BIMEKIZUMAB EFFICACY BY BODY REGION IN PLAQUE PSORIASIS: COMPARATIVE ANALYSES FROM FOUR PHASE 3/3B STUDIES

被引：0

作者：

Savage, Laura ^{[1
]}

Pinter, Andreas ^{[2
]}

Crowley, Jeffrey ^{[3
]}

Kerkhof, Peter van de ^{[4
]}

Armstrong, April ^{[5
]}

Kavanagh, Sarah ^{[6
]}

Wiegratz, Susanne ^{[7
]}

Hoepken, Bengt ^{[7
]}

Warren, Richard B. ^{[8
,9
]}

机构：

[1] Leeds Teaching Hosp NHS Trust, Leeds, England

[2] Univ Hosp Frankfurt, Frankfurt, Germany

[3] Bakersfield Dermatol, Bakersfield, CA USA

[4] Radboud Univ Nijmegen, Nijmegen, Netherlands

[5] Univ Calif Los Angeles UCLA, Los Angeles, CA USA

[6] UCB Pharm, Morrisville, NY USA

[7] UCB Pharm, Monheim, Germany

[8] Northern Care Alliance NHS Fdn Trust, Dermatol Ctr, Manchester, England

[9] Manchester Univ NHS Fdn Trust, NIHR Manchester Biomed Res Ctr, Manchester Acad Hlth Sci Ctr, Manchester Acad Hlth Sci Ctr Manchester, Manchester, England

来源：

ACTA DERMATO-VENEREOLOGICA | 2024年 / 104卷

关键词：

DOUBLE-BLIND; MULTICENTER; MODERATE; SAFETY;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P-061

引用

页数：102

共 50 条

[31] Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis Pooled Results From Phase 2 and Phase 3 Randomized Clinical Trials
Gordon, Kenneth B.
Langley, Richard G.
Warren, Richard B.
Okubo, Yukari
Gold, Linda Stein
Merola, Joseph F.
Peterson, Luke
Wixted, Krista
Cross, Nancy
Deherder, Delphine
Thaci, Diamant
JAMA DERMATOLOGY, 2022, 158 (07) : 735 - 744
[32] Psoriasis Symptoms and Impacts Measure (P-SIM) responses from the BE SURE bimekizumab in moderate to severe plaque psoriasis phase 3 trial
Warren, Richard B.
Augustin, Matthias
Gottlieb, Alice B.
Duffin, Kristina Callis
Ciaravino, Valerie
Cioffi, Christopher
Peterson, Luke
Blauvelt, Andrew
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB138 - AB138
[33] Efficacy and safety of oral tofacitinib in North American patients with moderate to severe plaque psoriasis: Pooled analyses of data from randomized phase 3 studies
Korman, Neil J.
King, Brett
Wolk, Robert
Tan, Huaming
Kaur, Mandeep
Robertson, Debbie
Langley, Richard
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB247 - AB247
[34] Psoriasis Symptoms and Impacts Measure (P-SIM) responses from the BE VIVID bimekizumab in moderate to severe plaque psoriasis phase 3 trial
Warren, Richard B.
Langley, Richard G.
Asahina, Akihiko
Augustin, Matthias
Merola, Joseph F.
Gottlieb, Alice B.
Ciaravino, Valerie
Cioffi, Christopher
Peterson, Luke
Lebwohl, Mark
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB137 - AB137
[35] Efficacy of tapinarof cream by body region in subjects with plaque psoriasis in a phase 2b randomized controlled study
Bissonnette, Robert
Gold, Linda Stein
Kircik, Leon
Tyring, Stephen K.
Tallman, Anna
Armstrong, April
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB62 - AB62
[36] Secukinumab efficacy in subjects with moderate to severe plaque psoriasis: Pooled subgroup analyses by patient age of 4 phase 3 clinical studies
Warren, Richard
Guettner, Achim
Morita, Akimichi
Gisondi, Paolo
Cooper, Simon
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB186 - AB186
[37] Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies
Pariser, David
Frankel, Ellen
Schlessinger, Joel
Poulin, Yves
Vender, Ronald
Langley, Richard G.
Meng, Xiangyi
Guana, Adriana
Nyirady, Judit
DERMATOLOGY AND THERAPY, 2018, 8 (01) : 17 - 32
[38] Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies
David Pariser
Ellen Frankel
Joel Schlessinger
Yves Poulin
Ronald Vender
Richard G. Langley
Xiangyi Meng
Adriana Guana
Judit Nyirady
Dermatology and Therapy, 2018, 8 : 17 - 32
[39] Secukinumab shows efficacy regardless of baseline disease severity in subjects with moderate-to-severe plaque psoriasis: a pooled analysis from four phase 3 studies
Spelman, L. J.
Blauvelt, A.
Loffler, J.
Fox, T.
Papavassilis, C.
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 : 73 - 73
[40] Bimekizumab efficacy and safety in Korean patients with moderate to severe plaque psoriasis: A phase 3, randomized, placebo-controlled, double-blinded study
Youn, Sang Woong
Jo, Seong Jin
Park, Chul Jong
Kim, Dong Hyun
Shin, Bong Seok
Jeong, Ki Heon
Bang, Chul Hwan
Cross, Nancy
Thirlwell, Jackie
Hoepken, Bengt
JOURNAL OF DERMATOLOGY, 2024, 51 (11): : 1392 - 1403

← 1 2 3 4 5 →